[HTML][HTML] COVID-19: systemic pathology and its implications for therapy
Q Shen, J Li, Z Zhang, S Guo, Q Wang… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Responding to the coronavirus disease 2019 (COVID-19) pandemic has been an
unexpected and unprecedented global challenge for humanity in this century. During this …
unexpected and unprecedented global challenge for humanity in this century. During this …
Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months
H Li, Z Liu, J Ge - Journal of cellular and molecular medicine, 2020 - Wiley Online Library
A cluster of pneumonia (COVID‐19) cases have been found in Wuhan China in late
December, 2019, and subsequently, a novel coronavirus with a positive stranded RNA was …
December, 2019, and subsequently, a novel coronavirus with a positive stranded RNA was …
COVID‐19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019‐nCoV disease
R Sheervalilou, M Shirvaliloo… - Journal of Cellular …, 2020 - Wiley Online Library
Months after the outbreak of a new flu‐like disease in China, the entire world is now in a
state of caution. The subsequent less‐anticipated propagation of the novel coronavirus …
state of caution. The subsequent less‐anticipated propagation of the novel coronavirus …
[HTML][HTML] Current understanding of novel coronavirus: molecular pathogenesis, diagnosis, and treatment approaches
An outbreak of “Pneumonia of Unknown Etiology” occurred in Wuhan, China, in late
December 2019. Later, the agent factor was identified and coined as severe acute …
December 2019. Later, the agent factor was identified and coined as severe acute …
[HTML][HTML] Understanding viral infection mechanisms and patient symptoms for the development of COVID-19 therapeutics
HM Choi, SY Moon, HI Yang, KS Kim - International Journal of Molecular …, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, has become a
worldwide pandemic. Symptoms range from mild fever to cough, fatigue, severe pneumonia …
worldwide pandemic. Symptoms range from mild fever to cough, fatigue, severe pneumonia …
[HTML][HTML] Recent understandings toward coronavirus disease 2019 (COVID-19): from bench to bedside
In late December 2019, an unprecedented outbreak of coronavirus disease 2019 (COVID-
19) caused by SARS coronavirus 2 (SARS-CoV-2)(previously named 2019-nCoV) in Wuhan …
19) caused by SARS coronavirus 2 (SARS-CoV-2)(previously named 2019-nCoV) in Wuhan …
[HTML][HTML] SARS-CoV-2: the monster causes COVID-19
Coronaviruses are viruses whose particles look like crowns. SARS-CoV-2 is the seventh
member of the human coronavirus family to cause COVID-19 which is regarded as a once-in …
member of the human coronavirus family to cause COVID-19 which is regarded as a once-in …
COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks
Today, the world population is facing an existential threat by an invisible enemy known as
severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) or COVID-19. It is highly …
severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) or COVID-19. It is highly …
[HTML][HTML] The molecular basis of COVID-19 pathogenesis, conventional and nanomedicine therapy
S Kouhpayeh, L Shariati, M Boshtam… - International journal of …, 2021 - mdpi.com
In late 2019, a new member of the Coronaviridae family, officially designated as “severe
acute respiratory syndrome coronavirus 2”(SARS-CoV-2), emerged and spread rapidly. The …
acute respiratory syndrome coronavirus 2”(SARS-CoV-2), emerged and spread rapidly. The …
An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic
Abstract Coronavirus disease 2019 (COVID-19) is an unprecedented disease caused by
highly pathogenic SARS-CoV-2 and characterized by extreme respiratory deterrence …
highly pathogenic SARS-CoV-2 and characterized by extreme respiratory deterrence …